Usana Health Sciences Inc DEFA14A, filed Mar 27, 2024
Usana Health Sciences Inc (USNA)
DEFA14A
2024-03-27
View Original
Added on
October 18, 2026
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934
(Mark One)
☒ Filed by the Registrant
☐ Filed by a Party other than the Registrant
Check the appropriate box:
| ☐ |
Preliminary Proxy Statement
|
| ☐ |
Confidential, For use of the Commission Only (as permitted by Rule 14a-6(e)(2))
|
| ☐ |
Definitive Proxy Statement
|
| ☒ |
Definitive Additional Materials
|
| ☐ |
Soliciting Material Pursuant to § 240.14a-12
|
|
USANA HEALTH SCIENCES, INC.
|
||
|
(Name of Registrant as Specified in its Charter)
|
||
|
(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)
|
Payment of Filing Fee (Check the appropriate box):
| ☒ |
No fee required.
|
| ☐ |
Fee paid previously with preliminary materials.
|
| ☐ |
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.
|
Persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays as
currently valid OMB control number.
